Open AccessSafety of Biologic Therapy in Liver Transplant Recipients: Case Closed?
Author(s) -
Brian Davis
Publication year - 2019
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz245
Subject(s) - medicine , liver transplantation , clostridioides , inflammatory bowel disease , intensive care medicine , inflammatory bowel diseases , liver disease , disease , transplantation , gastroenterology
Patients with inflammatory bowel disease who undergo liver transplantation may be considered for biologic therapy, but providers should closely monitor for infections such as cholangitis and Clostridioides difficile infection. Further research in prospective registries with long-term outcomes is needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom